Project will use big data and analytics to address pressing public health issue
Bettis unveils new playbook for defending against severe allergic reactions and affected to take action
First patient enrolled in Phase III clinical trial for moxetumomab pasudotox as a treatment for unresponsive or relapsed hairy cell leukemia patients
Simponi has already been approved by the FDA for the treatment of moderately to severely active rheumatoid arthritis
Like a game of whack-a-mole, no matter how many times Johnson & Johnson attempts to put to rest lawsuits over the marketing of its Risperdal...
Hello, everyone. Another shiny day here in the nation's medicine chest and we wonder what it will bring. Meanwhile, we have spent time hunting and gathering some of the latest developments. So grab a cup of stimulation - ours is percolating right now - and dig in. And have a good day...
Wyeth Admits Racial Remark But Wants Suit Tossed (LoHud.com)
Dutch Vioxx Users Take Merck To Court (DutchNews.nl)
Introgen Therapeutics Considers Its Options (Austin American-Statesmen)
